We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AHRNW
751
DELISTED
Ahren Acquisition Corp Warrants
AHRNW
– –
-50,578
Closed -$4.05K
HCNEW
752
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
– –
-40,149
Closed -$6.44K
DCP
753
DELISTED
DCP Midstream, LP
DCP
– –
-1,516,562
Closed -$58.8M
RONI.WS
754
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
– –
-27,453
Closed -$34.3K
PNTM.U
755
DELISTED
Pontem Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
PNTM.U
– –
-100,000
Closed -$1.01M
PNTM.WS
756
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
– –
-154,754
Closed -$12.4K
JNCE
757
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-3,647,430
Closed -$4.05M
MAXR
758
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
– –
-20,000
Closed -$587K
MAXR
759
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
– –
-10,000
Closed -$517K
HZON.WS
760
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
– –
-711,721
Closed -$292K
BMAQR
761
DELISTED
Blockchain Moon Acquisition Corp. Rights
BMAQR
– –
-29,080
Closed -$1.05K
BMAQW
762
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
– –
-41,760
Closed -$805
ALTIW
763
DELISTED
AlTi Global Inc Warrant
ALTIW
– –
-133,843
Closed -$68.5K
YTPG
764
DELISTED
TPG Pace Beneficial II Corp.
YTPG
– –
-64,547
Closed -$634K
VORBW
765
DELISTED
Virgin Orbit Holdings, Inc. Warrant
VORBW
– –
-27,200
Closed -$4.9K
MSDAW
766
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
– –
-85,332
Closed -$6.61K
SPKBW
767
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
– –
-168,758
Closed -$5.06K
NGC
768
DELISTED
Northern Genesis Acquisition Corp. III
NGC
– –
-250,810
Closed -$2.52M
RKTA
769
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
– –
-10,889
Closed -$110K
LDHAW
770
DELISTED
LDH Growth Corp I Warrant
LDHAW
– –
-239,667
Closed -$5.27K
KSICW
771
DELISTED
Kadem Sustainable Impact Corporation Warrant
KSICW
– –
-78,134
Closed -$804
FTPAW
772
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
– –
-674,821
Closed -$13.5K
FRONW
773
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
– –
-22,116
Closed -$256
CLAA.WS
774
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
– –
-20,717
Closed -$1.03K
PDOT.WS
775
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
– –
-265,135
Closed -$12.4K
29 30
31
32 33

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.